Literature DB >> 12190777

Neovascular age-related macular degeneration and its relationship to antioxidant intake.

E L M Snellen1, A L M Verbeek, G W P Van Den Hoogen, J R M Cruysberg, C B Hoyng.   

Abstract

PURPOSE: Experimental and epidemiological studies suggest that low antioxidant intake may be associated with the occurrence of neovascular age-related macular degeneration (AMD).
METHODS: We investigated this hypothesis further with a case-control study involving 72 case and 66 control patients attending the Ophthalmology Department of the University Hospital in Nijmegen. Data were collected by interview on antioxidant intake (i.e. in fruit and vegetables), cigarette smoking, sunlight exposure and familial predisposition. Antioxidant intake was calculated according to the method described in the Framingham Eye Study. Logistic regression analysis was used to estimate odds ratios (OR) and 95% confidence intervals (CI).
RESULTS: The prevalence rate of AMD in patients with low antioxidant intake and low lutein intake (dichotomized at the median value) was about twice as high as that in patients with high intake: OR = 1.7, 95% CI (0.8-3.7), and OR = 2.4, 95% CI (1.1-5.1). Further specification of intake data into quartiles of antioxidant intake and lutein/zeaxanthine intake showed a clear dose-response relationship.
CONCLUSION: The effect of dietary antioxidants upon macular health warrants preventive studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190777     DOI: 10.1034/j.1600-0420.2002.800404.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  28 in total

1.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

2.  ["Do you have a remedy for macular degeneration?" A field study about the advice given on dietary supplementation in 60 German pharmacies].

Authors:  F Ziemssen; M Warga; K U Bartz-Schmidt; H Wilhelm
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

3.  Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).

Authors:  Burkhard Dasch; Andrea Fuhs; Joachim Schmidt; Thomas Behrens; Astrid Meister; Juergen Wellmann; Manfred Fobker; Daniel Pauleikhoff; Hans-Werner Hense
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

4.  In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and heterochromatic flicker photometry.

Authors:  R E Hogg; R S Anderson; M R Stevenson; M B Zlatkova; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

5.  [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].

Authors:  M Zeimer; H W Hense; B Heimes; U Austermann; M Fobker; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

Review 6.  The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field.

Authors:  John Paul SanGiovanni; Martha Neuringer
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

Review 7.  Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration.

Authors:  Euna Koo; Martha Neuringer; John Paul SanGiovanni
Journal:  Am J Clin Nutr       Date:  2014-05-14       Impact factor: 7.045

Review 8.  Nutrition effects on ocular diseases in the aging eye.

Authors:  Emily Y Chew
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

9.  The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

Authors:  Emily Y Chew; Traci Clemons; John Paul SanGiovanni; Ronald Danis; Amitha Domalpally; Wendy McBee; Robert Sperduto; Frederick L Ferris
Journal:  Ophthalmology       Date:  2012-07-26       Impact factor: 12.079

10.  Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults.

Authors:  Lei Li; C-Y Oliver Chen; Giancarlo Aldini; Elizabeth J Johnson; Helen Rasmussen; Yasukazu Yoshida; Etsuo Niki; Jeffrey B Blumberg; Robert M Russell; Kyung-Jin Yeum
Journal:  J Nutr Biochem       Date:  2009-05-15       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.